Darling Ingredients ( (DAR) ) has released its Q2 earnings. Here is a breakdown of the information Darling Ingredients presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Darling Ingredients Inc. is a global leader in transforming animal and food by-products into sustainable ingredients for various industries, including renewable energy, food, and agriculture. The company operates over 260 facilities across more than 15 countries, processing a significant portion of the world’s animal agricultural by-products and producing a substantial share of the world’s collagen.
In its second-quarter earnings report for 2025, Darling Ingredients announced a net income of $12.7 million, or $0.08 per diluted share, on total net sales of $1.5 billion. The company highlighted its strategic move to refinance long-term debt and the signing of a non-binding term sheet to establish Nextida, a new venture focused on collagen and gelatin.
Key financial metrics revealed a decline in net income from $78.9 million in the same quarter of 2024, primarily due to lower earnings from the Diamond Green Diesel (DGD) joint venture. Despite this, the company maintained stable net sales year-over-year. The combined adjusted EBITDA for the quarter was $249.5 million, down from $273.6 million in 2024. Darling Ingredients also reported a net loss of $13.5 million for the first half of 2025, a significant drop from the $160 million net income in the first half of 2024.
Strategically, Darling Ingredients is focusing on enhancing its financial flexibility and advancing its growth agenda. The launch of Nextida is expected to unlock value in the high-potential health and wellness markets, aligning with the company’s broader goals in renewable energy and sustainable ingredients.
Looking ahead, Darling Ingredients anticipates improvement in its core ingredients business, driven by strengthening fat prices and regulatory support for biofuels. However, global tariffs and supply chain disruptions pose ongoing challenges. The company has adjusted its 2025 outlook for combined adjusted EBITDA to a range of $1.05-$1.10 billion, reflecting these market dynamics.